Article PDF
Avoid common mistakes on your manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published with open access at link.springer.com
Biographical Sketch
Professor Li LanJuan, a M.D. supervisor, academician of the CAE (Chinese Academy of Engineering) and chief physician of the First Affiliated Hospital of Zhejiang University, is a famous infectious disease specialist in China and she has been engaged in clinical, teaching and scientific research work in the field of infectious diseases for 40 years. She is a pioneer in the study of artificial liver in China and established a special and effective artificial liver system (Li's artificial liver system (Li-ALS)), which was a momentous breakthrough in the treatment of severe hepatitis. Professor Li has also made great achievements in microecology research by developing new infectious microecology theories that explore the occurrence, development, and outcome of infection from the microecological perspective, and by proposing new strategies for the prevention and control of infections. In addition, she has undertaken more than 10 key research projects such as the national science fund project, National High Technology Research and Development Program of China and National Basic Research Program of China and so on. She has 22 authorized invention patents and has published more than 400 papers, over 150 collected by SCI academic journals including The Lancet and The New England Journal of Medicine. Served as the first completed, she has won several prizes including first prize of National Science and Technology Progress, and second prize of National Science and Technology Progress twice, first prizes of Science and Technology Progress of Zhejiang Province five times, and the second prize of Popularization and Application of Award in Colleges and Universities granted by the Ministry of Education. Presently, she holds the post of director of the State Key Laboratory for the Diagnosis of Infectious Diseases, the Leader of State Key Discipline Department of Internal Medicine (Infectious Diseases), and also director of the Zhejiang Infectious Disease Key Laboratory.
Meanwhile, she is also the director of the Department of Bio-Medicine of the Ministry of Education, vice chairman of the Chinese Medical Association (CMA), vice president of the Chinese Health Information Society (CHIA), deputy chairman of the Chinese Society of Biomedical Engineering (CSBE), and director of the National Artificial Liver Training Base, division chief of the Microecology Branch of Chinese Preventive Medicine Association (CPMA), division chief of the Infectious Diseases Branch of Chinese Medical Doctor Association (CDMA), a vice-chairman member of the Third Cloud Computing Expert Committee of Chinese Institute of Electronics (CIE), chairman of the International Human Microbiome Consortium (IHMC), board trustees of the International Society for Apheresis (ISFA), president of Zhejiang Medical Association, editor-in-chief of the Chinese Journal of Clinical Infectious Diseases, Chinese Journal of Microecology and Zhejiang Medical Journal, vice editor-in-chief of the Chinese Journal of Infectious Diseases and International Journal of Epidemiology and Infectious Disease. She has edited and published 28 monographs including the first edition of “Artificial Liver” and “Infectious Microecology” of China; and planned textbooks of Epidemiology. Furthermore, she also holds the position of vice chief engineer of the “Twelfth Five-Year Plan”—a major science-technology project titled “Prevention and Treatment of AIDS and Viral Hepatitis and Other Major Infectious Diseases” and is the expert team leader of “Field Study at Comprehensive Prevention and Control Demonstration Area”. In 2010, she won the title of “National Excellent Science and Technology Workers” for her great contribution to the diagnosis and treatment of infectious disease.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Li, L. Suggestions to the hepatitis B vaccine events. Sci. China Life Sci. 57, 551–552 (2014). https://doi.org/10.1007/s11427-014-4626-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-014-4626-1